Skip to content

The role of insulin therapy in reducing critical illness polyneuropathy and myopathy in pediatric intensive care unit

The role of insulin therapy in reducing critical illness polyneuropathy and myopathy in pediatric intensive care unit

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201108117295N1
Enrollment
30
Registered
2012-02-16
Start date
2010-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polyneuropathy and myopathy. Diabetic polyneuropathy

Interventions

Intervention 1: In this study,during one year and a half,30 of patients admitted to the pediatric intensive care unit of Tabriz Children's Hospital and are more than one week under mechanical ventilat
In first group with 15 patients,in which the intervention is done, insulin is used in order to keep blood sugar in range of 140-180 milligram per decilitre (until the patient is connected to the venti
Treatment - Drugs
In this study,during one year and a half,30 of patients admitted to the pediatric intensive care unit of Tabriz Children's Hospital and are more than one week under mechanical ventilation and in the c
In second group with 15 patients which is called control group,distilled water as placebo will be used.Appropriate protocol in using distilled water,like insulin injection in intervened group,is conti

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria and who are under investigation in this study are the following: In this study,during one year and a half,30 of patients admitted to the pediatric intensive care unit of Tabriz Children's Hospital and are more than one week under mechanical ventilation and in the course of their hospitalization experience hyperglycemia (more than 180 milligram per decilitre) are divided into two groups; In first group with 15 patient insulin is used in order to keep blood sugar in range of 140-180 milligram per decilitre (until the patient is connected to the ventilator); In second group with 15 patient,distilled water as placebo will be used (Note that injection will be done by a person who has no information about the polyneuropathy and myopathy). Confounding variables are important in this study and the following people are excluded from study; spinal cord injuries; patients with Guillain Barre Syndrome; myasthenia gravis; patients with central nervous system problems or neuromuscular disease causing muscle weakness and paralysis before or during the hospitalization; hypophosphatemia. Appropriate methods to control confounding variables are according to observation,periods of physical examination,laboratory results such as blood and cerebro spinal fluid tests and EMG and NCV. It should be noted that the removal of these patients are so that in each point of the study (before the start of or during the study) if each of 5 problems above found by methods such as Electromygraphy and testing of cerebrospinal fluid or physical examination period,the patient will be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: Serial monitoring of blood glucose per hour (the aim of maintaining blood glucose range 140-180 milligram per decilitre). Method of measurement: Glucometry.

Secondary

MeasureTime frame
Polyneuropathy and myopathy. Timepoint: After extubation. Method of measurement: Electromyography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahram Sadegvand

Tabriz University of Medical Sciences

shahramsharar@gmail.com+98 41 1668 0691

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026